Talk to our Consultant - Anti-Obesity Drugs Market Size, Share Growth Report by 2032

Global Anti-Obesity Drugs Market Research Report: Forecast (2026-2032)

Anti-Obesity Drugs Market - By Drug Class (Centrally Acting Drugs, Appetite Suppressants, Neurotransmitter Modulators, Peripherally Acting Drugs, Lipase Inhibitors, Fat Absorption Blockers, Combinatio... ... Blockers, Combination Drugs), By Drug Type (Prescription Drugs, Over The Counter (OTC) Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Route of Administration (Oral, Injectable, Others), By Patient Indication (Adults with Obesity, Overweight Individuals, Individuals with Obesity + Comorbidities), and others Read more

Healthcare
Dec 2025
Pages 198
Report Format: PDF, Excel, PPT

Global Anti-Obesity Drugs Market Size: Forecast (2026-2032)

The Global Anti-Obesity Drugs Market size is valued at around USD15.3 billion in 2025 and is projected to reach USD49.68 billion by 2032. Along with this, the market is estimated to grow at a CAGR of around 21.69% during the forecast period, i.e., 2026-32.

Global Anti-Obesity Drugs Market Outlook:

The Global Anti-Obesity Drugs Market is entering a high-growth phase as rising obesity levels, strong clinical evidence, and growing government and industry investments converge. For instance, one in eight people worldwide was living with obesity in 2022, reflecting a rapid surge driven by sedentary lifestyles, calorie-dense diets, and urbanization, as per the WHO. This escalating burden is prompting governments to strengthen national strategies. For reference, Australia allocated USD513 million across 186 obesity-prevention initiatives between 2013 and 2022, while the UK’s 2025 Obesity Healthcare Goals focus on expanding access to weight-management services and encouraging therapeutic innovation.

This public-sector attention aligns with major regulatory advancements. The FDA’s approvals of tirzepatide (Zepbound) for chronic weight management and expanded Wegovy indications, now including cardiovascular-risk reduction, have improved clinical confidence and broadened patient eligibility. Additionally, rising healthcare spending in the U.S., Japan, and China is increasing demand for medical obesity interventions.

Additionally, at the industry level, investment is accelerating. Novo Nordisk has committed over billions of dollars to expand obesity-drug manufacturing, including a major facility in North Carolina. Meanwhile, Eli Lily announced a USD1.8 billion expansion in Ireland and a further USD6.5 billion investment to build a plant for its future oral weight-loss drug, including GLP-1 production capacity, signaling unprecedented scale-up efforts. R&D pipelines are also expanding rapidly, with companies pursuing next-generation agents such as triple-agonists, oral GLP-1s, and combination therapies.

Overall, rising obesity prevalence, stronger government initiatives, supportive regulatory actions, and record-high R&D and manufacturing investments are creating a powerful growth landscape for the Global Anti-Obesity Drugs Market.

Global Anti-Obesity Drugs Market Recent Developments:

2025: AstraZeneca exercised its option to acquire SixPeaks Bio, a Swiss biotech focused on obesity therapies, making a first payment of USD170 million, with another USD30 million due in two years and up to USD100 million in additional milestone payments tied to regulatory success.
2025: Roche entered a major partnership with Zealand Pharma to develop and commercialize the obesity drug petrelintide. The deal is worth up to USD5.3 billion. Under the agreement, both companies will co-market the drug in the U.S. and Europe, while Roche will have exclusive rights in all other regions.

Global Anti-Obesity Drugs Market Scope:

Category	Segments
By Type	Bathroom Sanitary Fittings [Toilet Seats, Faucets, Showers & Hand Showers, Accessories, Wall Cabinets], Kitchen Sanitary Fittings [Faucets, Cabinets]
By End User	Residential, Commercial & Retail, Hospitality, Healthcare, Government & Transport, Others
By Sales Channel	Direct Sales, Dealers & Distributors

Global Anti-Obesity Drugs Market Drivers:

Rising Cases of Obesity Driving Market Demand

Rising obesity rates across major economies are a major driver of this market, as they create a rapidly expanding population that requires long-term medical treatment. For instance, the World Health Organization’s 2024 update confirms that 43% of adults worldwide are overweight and 16% are obese, showing that obesity is now a widespread global disease burden. Also, in 2024, over 35 million children under age 5 had obesity.

Additionally, China CDC Weekly (2024–2025) estimated that around 50% of Chinese adults are overweight or obese, showing high obesity among adults, highlighting demographic variation. Moreover, the OECD 2025 report shows that 54% of adults across OECD member nations, including Germany, are overweight or obese, with obesity commonly ranging from 19–26% across European countries. Together, these rising prevalence levels across major economies confirm strong, sustained demand for pharmacological obesity treatments.

Market Segmentation
Introduction
1. Market Definition
2. Research Process
3. Assumption
Executive Summary
Global Anti-Obesity Drugs Market Trends & Development
Global Anti-Obesity Drugs Market Dynamics
1. Growth Drivers
2. Challenges
Global Anti-Obesity Drugs Market Hotspot & Opportunities
Global Anti-Obesity Drugs Market Regulation & Policy
Global Anti-Obesity Drugs Market Outlook, 2022-2032F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug Class
    1. Centrally Acting Drugs- Market Size & Forecast 2022-2032, USD Million
      1. Appetite Suppressants- Market Size & Forecast 2022-2032, USD Million
      2. Neurotransmitter Modulators- Market Size & Forecast 2022-2032, USD Million
    2. Peripherally Acting Drugs- Market Size & Forecast 2022-2032, USD Million
      1. Lipase Inhibitors- Market Size & Forecast 2022-2032, USD Million
      2. Fat Absorption Blockers- Market Size & Forecast 2022-2032, USD Million
    3. Combination Drugs- Market Size & Forecast 2022-2032, USD Million
  2. By Drug Type
    1. Prescription Drugs- Market Size & Forecast 2022-2032, USD Million
    2. Over The Counter (OTC) Drugs- Market Size & Forecast 2022-2032, USD Million
  3. By Distribution Channel
    1. Hospital Pharmacies- Market Size & Forecast 2022-2032, USD Million
    2. Retail Pharmacies- Market Size & Forecast 2022-2032, USD Million
    3. Online Pharmacies- Market Size & Forecast 2022-2032, USD Million
  4. By Route of Administration
    1. Oral- Market Size & Forecast 2022-2032, USD Million
    2. Injectable- Market Size & Forecast 2022-2032, USD Million
    3. Others- Market Size & Forecast 2022-2032, USD Million
  5. By Patient Indication
    1. Adults with Obesity- Market Size & Forecast 2022-2032, USD Million
    2. Overweight Individuals- Market Size & Forecast 2022-2032, USD Million
    3. Individuals with Obesity + Comorbidities- Market Size & Forecast 2022-2032, USD Million
  6. By Region
    1. North America
    2. South America
    3. Europe
    4. The Middle East & Africa
    5. Asia-Pacific
  7. By Company
    1. Competition Characteristics
    2. Revenue Shares
North America Anti-Obesity Drugs Market Outlook, 2022-2032F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
  2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
  3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
  4. By Route of Administration- Market Size & Forecast 2022-2032, USD Million
  5. By Patient Indication- Market Size & Forecast 2022-2032, USD Million
  6. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Anti-Obesity Drugs Market Outlook, 2022-2032F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
    2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
    3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
4. Canada Anti-Obesity Drugs Market Outlook, 2022-2032F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
    2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
    3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
5. Mexico Anti-Obesity Drugs Market Outlook, 2022-2032F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
    2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
    3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
South America Anti-Obesity Drugs Market Outlook, 2022-2032F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
  2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
  3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
  4. By Route of Administration- Market Size & Forecast 2022-2032, USD Million
  5. By Patient Indication- Market Size & Forecast 2022-2032, USD Million
  6. By Country
    1. Brazil
    2. Argentina
    3. Rest of South America
3. Brazil Anti-Obesity Drugs Market Outlook, 2022-2032F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
    2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
    3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
4. Argentina Anti-Obesity Drugs Market Outlook, 2022-2032F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
    2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
    3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
Europe Anti-Obesity Drugs Market Outlook, 2022-2032F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
  2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
  3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
  4. By Route of Administration- Market Size & Forecast 2022-2032, USD Million
  5. By Patient Indication- Market Size & Forecast 2022-2032, USD Million
  6. By Country
    1. The UK
    2. Germany
    3. France
    4. Italy
    5. Spain
    6. Rest of Europe
3. The UK Anti-Obesity Drugs Market Outlook, 2022-2032F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
    2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
    3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
4. Germany Anti-Obesity Drugs Market Outlook, 2022-2032F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
    2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
    3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
5. France Anti-Obesity Drugs Market Outlook, 2022-2032F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
    2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
    3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
6. Italy Anti-Obesity Drugs Market Outlook, 2022-2032F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
    2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
    3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
7. Spain Anti-Obesity Drugs Market Outlook, 2022-2032F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
    2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
    3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
The Middle East & Africa Anti-Obesity Drugs Market Outlook, 2022-2032F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
  2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
  3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
  4. By Route of Administration- Market Size & Forecast 2022-2032, USD Million
  5. By Patient Indication- Market Size & Forecast 2022-2032, USD Million
  6. By Country
    1. Saudi Arabia
    2. The UAE
    3. South Africa
    4. Rest of the Middle East & Africa
3. Saudi Arabia Anti-Obesity Drugs Market Outlook, 2022-2032F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
    2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
    3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
4. The UAE Anti-Obesity Drugs Market Outlook, 2022-2032F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
    2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
    3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
5. South Africa Anti-Obesity Drugs Market Outlook, 2022-2032F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
    2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
    3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
Asia-Pacific Anti-Obesity Drugs Market Outlook, 2022-2032F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
  2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
  3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
  4. By Route of Administration- Market Size & Forecast 2022-2032, USD Million
  5. By Patient Indication- Market Size & Forecast 2022-2032, USD Million
  6. By Country
    1. China
    2. Japan
    3. South Korea
    4. India
    5. Australia
    6. Rest of Asia-Pacific
3. China Anti-Obesity Drugs Market Outlook, 2022-2032F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
    2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
    3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
4. Japan Anti-Obesity Drugs Market Outlook, 2022-2032F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
    2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
    3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
5. South Korea Anti-Obesity Drugs Market Outlook, 2022-2032F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
    2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
    3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
6. India Anti-Obesity Drugs Market Outlook, 2022-2032F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
    2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
    3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
7. Australia Anti-Obesity Drugs Market Outlook, 2022-2032F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Size & Analysis
    1. By Drug Class- Market Size & Forecast 2022-2032, USD Million
    2. By Drug Type- Market Size & Forecast 2022-2032, USD Million
    3. By Distribution Channel- Market Size & Forecast 2022-2032, USD Million
Global Anti-Obesity Drugs Market Key Strategic Imperatives for Success & Growth
Competitive Outlook
1. Company Profiles
  1. Novo Nordisk A/S
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. Eli Lilly & Company
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. Pfizer Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. F. Hoffmann-La Roche Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. GlaxoSmithKline plc
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Boehringer Ingelheim International GmbH
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  7. Amgen Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  8. AstraZeneca plc
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  9. Merck & Co., Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  10. Rhythm Pharmaceuticals, Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  11. Currax Pharmaceuticals LLC
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  12. VIVUS, LLC
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  13. Gelesis, Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  14. Takeda Pharmaceutical Co. Ltd
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  15. Zydus Lifesciences Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  16. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying